EcoDrugPlus

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSUPAG00010016474
Gene Symbol: NTRK3
3 Cross references
269 Possible Orthologues:

Nicastrin

Ensembl ID : ENSUPAG00010011309
Gene Symbol: NCSTN
3 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSUPAG00010013886
Gene Symbol: NAMPT
1 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSUPAG00010004304
Gene Symbol: NISCH
1 Cross references
208 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSUPAG00010022398
Gene Symbol: NOS2
1 Cross references
163 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSUPAG00010006771
Gene Symbol: NOTCH1
1 Cross references
273 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSUPAG00010001075
Gene Symbol: NOTCH3
3 Cross references
200 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSUPAG00010012431
Gene Symbol: NFKB1
3 Cross references
200 Possible Orthologues:

Nuclear Factor Kappa B Subunit 2

Ensembl ID : ENSUPAG00010020673
Gene Symbol: NFKB2
3 Cross references
124 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 2

Ensembl ID : ENSUPAG00010014907
Gene Symbol: NR1H2
1 Cross references
305 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 3

Ensembl ID : ENSUPAG00010011188
Gene Symbol: NR1H3
1 Cross references
391 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 4

Ensembl ID : ENSUPAG00010003387
Gene Symbol: NR1H4
3 Cross references
387 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).